These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 10745594)

  • 1. Worse six-month outcome for patients with multiple stents in a single coronary artery.
    Gaxiola E; Vlietstra RE; Browne KF; Ebersole DG; Brenner AS; Weeks TT; Mines MH; Roman L; Kerensky RA
    J Invasive Cardiol; 1999 Sep; 11(9):549-54. PubMed ID: 10745594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major adverse cardiac events at long-term follow-up in patients treated with single versus multiple stents during single-vessel percutaneous coronary intervention.
    Sukhija R; Aronow WS; Palaniswamy C; Singh T; Ahn C; Kalapatapu K; Chaturvedi B; Pucillo AL; Sorbera C; Kakar P; Weiss MB; Mehta V; Monsen CE
    J Interv Cardiol; 2009 Oct; 22(5):427-30. PubMed ID: 19627434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical outcome in patients after single vessel PTCA with multiple stent implantation].
    Pieniazek P; Przewłocki T; Zmudka K; Dudek D; Sedziwy E; Olszowska M; Kostkiewicz M; Kapelak B; Tracz W
    Przegl Lek; 2001; 58(6):479-83. PubMed ID: 11816735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient.
    Ruygrok PN; Webster MW; Ardill JJ; Chan CC; Mak KH; Meredith IT; Stewart JT; Ormiston JA; Price S
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):165-71. PubMed ID: 12772233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
    Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosis.
    Kuchulakanti P; Torguson R; Canos D; Satler LF; Suddath W; Chan R; White LR; Gevorkian N; Bui A; Wang B; Kent KM; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2005; 6(3):108-12. PubMed ID: 16275606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent placement to prevent restenosis after angioplasty in small coronary arteries.
    Doucet S; Schalij MJ; Vrolix MC; Hilton D; Chenu P; de Bruyne B; Udayachalerm W; Seth A; Bilodeau L; Reiber JH; Harel F; Lespérance J;
    Circulation; 2001 Oct; 104(17):2029-33. PubMed ID: 11673341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.
    Agema WR; Monraats PS; Zwinderman AH; De Winter RJ; Tio RA; Doevendans PA; Waltenberger J; De Maat MP; Frants RR; Atsma DE; Van Der Laarse A; Van Der Wall EE; Jukema JW
    Eur Heart J; 2004 Jul; 25(13):1163-70. PubMed ID: 15231375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.